Intermittent renal replacement therapy (IRRT) is prescribed across intensive care units (ICU) worldwide. While research regarding the prescribed dialysis dose has not yielded results concerning mortality, it is still unknown whether the same applies to the actual delivered dose.
We retrospectively analyzed two different cohorts of patients (562 IRRT sessions) who were admitted to the intensive care units at Hospital Clínic of Barcelona and required renal replacement therapy with IRRT. The first cohort included patients with acute kidney injury (AKI) (n = 42) and the second included patients already on chronic hemodialysis (CKD 5D) (n = 47). Only patients who had at least 3 recorded hemodialysis sessions in the ICU and with no previous continuous renal replacement therapy (CRRT) were included. The achieved dose was measured as Kt (L) by ionic dialysance and the primary endpoint was 90-day mortality.
Ninety-day mortality was 40.5% (n = 17) in the AKI cohort and 23.9% (n = 11) in the CKD 5D cohort with mean Kt of 43 ± 8.27 L and 47 ± 9.65 L respectively. Kt dose of IRRT was associated with 90-day mortality in the AKI cohort in a multivariate surveillance analysis adjusted for confounding factors (HR 0.935 [0.88–0.99], p = 0.02). Only the Kt dose and age remained statistically associated with the outcome in the AKI cohort.
Delivered dialysis dose as measured by ionic-dialysance Kt may be associated with survival in critically-ill patients with AKI, while it does not seem to affect outcomes in critically-ill CKD 5D patients. This exploratory analysis will need confirmation in larger prospective studies.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Rizo-Topete LM, Arellano-Torres M, Hernández-Portales J, Treviño-frutos R, Monreal-puente R (2015) Renal replacement therapies in acute kidney injury in Intensive Care Unit, continuous renal replacement, hybrid, and conventional hemodialysis: survival analysis. Dial Traspl 36:8–14
Liangos O, Wald R, O’Bell JW, Price L, Pereira BJ, Jaber BL (2006) Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 1(1):43–51
Ostermann M, Chang RW (2007) Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 35(8):1837–1843
Szamosfalvi B, Yee J (2013) Considerations in the critically ill ESRD patient. Adv Chronic Kidney Dis 20(1):102–109
Uehlinger DE, Jakob SM, Ferrari P et al (2005) Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transpl 2(8):1630–1637
Schefold JC, von Haehling S, Pschowski R et al (2014) The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit Care 18(1):R11
Lins RL, Elseviers MM, Van der Niepen P et al (2009) Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transpl 24(2):512–518
Jun M, Heerspink HJ, Ninomiya T et al (2010) Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 5(6):956–963
Nash DM, Przech S, Wald R, O’Reilly D (2017) Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care 41:138–144
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) Clinical practice guidelines for acute kidney injury. Kidney Int 2:1–138
Schwenger V, Weigand MA, Hoffmann O et al (2012) Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury—a randomized interventional trial: the renal replacement therapy study in intensive care unit patients. Crit Care 16(5):451
Lyndon WD, Wille KM, Tolwani AJ (2012) Solute clearance in CRRT: prescribed dose versus actual delivered dose. Nephrol Dial Transpl 27(3):952–956
Vesconi S, Cruz DN, Fumagalli R et al (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13(2):R57
Macedo E, Claure-Del Granado R, Mehta RL (2011) Effluent volume and dialysis dose in CRRT: time for reappraisal. Nat Rev Nephrol 8(1):57–60
Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NK (2010) High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med 38(5):1360–1369
Bellomo R, Cass A, RENAL Replacement Therapy Study Investigators et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361(17):1627–1638
Palevsky PM, Zhang JH, VA/NIH Acute Renal Failure Trial Network et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359(1):7–20
Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346(5):305–310
Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 347:2010–2019
Maduell F, Ramos R, Varas J et al (2016) Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk. Kidney Int 90(6):1332–1341
Gotch FA, Sargent JA, Keen ML (2000) Whither goest Kt/V? Kidney Int Suppl 76:S3–S18
Clark WR, Mueller BA, Kraus MA et al (1998) Renal replacement therapy quantification in acute renal failure. Nephrol Dial Transpl 13(Suppl 6):86–90
Schiffl H, Fischer R, Lang SM (2014) Assessment of dialysis dose in critically ill maintenance dialysis patients. Ther Apher Dial 18(5):468–472
Lindsay RM, Bene B, Goux N, Heidenheim AP, Landgren C, Sternby J (2001) Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis. Am J Kidney Dis 38(3):565–574
Ridel C, Osman D, Mercadal L et al (2007) Ionic dialysance: a new valid parameter for quantification of dialysis efficiency in acute renal failure? Intensive Care Med 33(3):460–465
Maduell F, Ramos R, Palomares I et al (2013) Impact of targeting Kt instead of Kt/V. Nephrol Dial Transpl 28(10):2595–2603
Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF (1999) The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 56(2):729–737
Ahmad S, Misra M, Hoenich N, Daugirdas JT (2007) Hemodialysis apparatus. In: Daugirdas JT, Blake PG, Ing TS (eds) Handbook of dialysis, 4th edn. Williams & Wilkins, Philadelphia, USA
Faulhaber-Walter R, Hafer C, Jahr N et al (2009) The hannover dialysis outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transpl 24:2179
Rabb H, Griffin MD, McKay DB et al (2016) Inflammation in AKI: current understanding, key questions, and knowledge gaps. J Am Soc Nephrol 27(2):371–379
Park JT, Kee YK, Oh HJ et al (2016) High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 68(4):599–608
Joannes-Boyau O, Honoré PM, Perez P et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:1535–1546
Serra Cabañas N, Barros Freiria X, Martinez Garro M, Blasco Pelícano M, Maduell Canals F, Torras Rabasa A et al (2010) La medida de la dosis de diálisis mediante Kt por dialisancia iónica revela una menor adecuación que la medida por Kt/Vurea en la insuficiencia renal aguda de pacientes críticos. Nefrología 30(2):232–235
Simmons J, Pittet J-F (2015) The coagulopathy of sepsis. Curr Opin Anaesthesiol 28(2):227–236
Murray PT, Brady HR, Hall JB (2006) Intensive care in nephrology. Taylor and Francis, Abingdon
Hospital Clínic Intensive Care Working Group (GTMC, Grup de treball del Malalt crític): Sara Fernández, Josep Maria Nicolàs, Pedro Castro, Intensive Care Unit, Internal Medicine Department, Hospital Clínic, IDIBAPS; Rut Andrea, Xavier Bosch, José Tomás Ortiz, Acute Cardiac Care, Cardiology Department, Hospital Clínic, IDIBAPS; Enric Reverter, Javier Fernández, Àngels Escorsell, Intensive Care Unit, Hepatology Department, Hospital Clínic, IDIBAPS; Jordi Mercadal, Carlos Ferrando, Xavier Borrat, Surgical ICU, Anesthesiology Department, Hospital Clínic, IDIBAPS; Antoni Torres, Joan Ramón Badia, Miquel Ferrer, Intensive Care Unit, Pneumology Department, Hospital Clínic, IDIBAPS; Eduard Quintana, Daniel Pereda, Elena Sandoval, Manel Castellà, Irene Rovira, Intensive care unit, Cardiovascular-Surgery Department, Hospital Clínic, IDIBAPS.
The authors received no financial support for the research, authorship, and publication of this article.
Conflict of interest
No potential conflict of interest was reported by the authors. The results presented in this paper have not been published previously in whole or part, except in abstract format.
The Study was approved by the Ethics Committee of the Hospital Clinic and conformed to the ethical guidelines of the Helsinki Declaration (as revised in Tokyo 2004).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Molina-Andújar, A., Alcubilla, P., Santiago, P. et al. Impact of the intensity of intermittent renal replacement therapy in critically ill patients. J Nephrol 34, 105–112 (2021). https://doi.org/10.1007/s40620-020-00760-x
- Intermittent renal replacement therapy
- Dialysis dose
- Acute kidney injury
- Intensive care unit
- Ionic dialysance